Gayle S. Lawson

FDA investigator

Appears on 10 documents from 2015 to 2019, mostly at sites in Pennsylvania. Most often cites responsibilities of quality control unit (21 CFR 211.22).

10
Documents on file
6.0
Observations per 483
2015
First seen
2019
Most recent

What they cite most

From 60 observations

Activity by year

2015: 3, 2016: 1, 2017: 3, 2018: 1, 2019: 2

Where

Pennsylvania 7 · India 2 · Virginia 1

Is Gayle S. Lawson coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Aurobindo Pharma Limited Unit VIII Survey No. 10 & 13, Gaddapotharam Village IDA KazipallyOct 25, 2019 · Jinnaram Mandal, India
483 Afton Scientific, LLCJun 14, 2019 · Charlottesville, Virginia
483 Central Admixture Pharmacy Services, Inc.Aug 22, 2018 · Allentown, Pennsylvania
483 Almac Pharma Services LLCDec 7, 2017 · Audubon, Pennsylvania
483 Dr. Reddy’s Laboratories Limited CTO VI APIIC Industrial Estate, Pydibhimavarma (Village)Apr 4, 2017 · Srikakulam District, India
483 Hieber's PharmacyFeb 17, 2017 · Pittsburgh, Pennsylvania
483 ImprimisRx Pharmacy, LLCAug 1, 2016 · Folcroft, Pennsylvania

About this profile

What does Gayle S. Lawson inspect?

Gayle S. Lawson appears on 10 documents on file covering 10 sites, mostly in Pennsylvania.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.192 and 21 CFR 211.194.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Gayle S. Lawson is dated Oct 25, 2019.